An efficient synthesis and evaluation of some novel quinazolinone-pyrazole hybrids as potential antiproliferative agents

References

• Shagufta, A. I. Sulfones: An Important Class of Organic Compounds with Diverse Biological Activities. Int. J. Pharm. Sci. 2015, 7, 19–27.
   Google Scholar
• Shagufta, A. I. Recent Insight into the Biological Activities of Synthetic Xanthone Derivatives. Eur. J. Med. Chem. 2016, 116, 267–280. DOI: 10.1016/j.ejmech.2016.03.058.
   PubMed Web of Science ®Google Scholar
• Demeunynck, M.; Baussanne, I. Survey of Recent Literature Related to the Biologically Active 4(3H)-Quinazolinones Containing Fused Heterocycles. CMC. 2013, 20, 794–814. DOI: 10.2174/0929867311320060006.
   PubMed Web of Science ®Google Scholar
• Hekal, M. H.; Abu El-Azm, F. S. M. New Potential Antitumor Quinazolinones Derived from Dynamic 2-Undecyl Benzoxazinone: Synthesis and Cytotoxic Evaluation. Synth. Commun. 2018, 48, 2391–2402. DOI: 10.1080/00397911.2018.1490433.
   Web of Science ®Google Scholar
• Hekal, M. H.; Abu El-Azm, F. S. M.; Atta-Allah, S. R. Ecofriendly and Highly Efficient Microwave-Induced Synthesis of Novel Quinazolinone-Undecyl Hybrids with in vitro Antitumor Activity. Synth. Commun. 2019, 49, 2630–2641. DOI: 10.1080/00397911.2019.1637001.
   Web of Science ®Google Scholar
• Girmenia, C.; Finolezzi, E. New-Generation Triazole Antifungal Drugs: Review of the Phase II and III Trials. Clin. Investig. 2011, 1, 1577–1594. DOI: 10.4155/cli.11.137.
   Google Scholar
• Purcell, J. W.; Davis, J.; Reddy, M.; Martin, S.; Samayoa, K.; Vo, H.; Thomsen, K.; Bean, P.; Kuo, W. L.; Ziyad, S.; et al. Activity of the Kinesin Spindle Protein Inhibitor Ispinesib (sb-715992) in Models of Breast Cancer. Clin. Cancer Res. 2010, 16, 566–576. DOI: 10.1158/1078-0432.CCR-09-1498.
   PubMed Web of Science ®Google Scholar
• Do, B.; Mace, M.; Rexwinkle, A. Idelalisib for Treatment of B-Cell Malignancies. Am. J. Health. Syst. Pharm. 2016, 73, 547–555. DOI: 10.2146/ajhp150281.
   PubMed Web of Science ®Google Scholar
• Abida  , An Updated Review: Newer Quinazoline Derivatives Under Clinical Trial. Int. J. Pharm. Biol. Arch. 2011, 2, 1651–1657.
   Google Scholar
• Derbyshire, E. R.; Mazitschek, R.; Clardy, J. Characterization of Plasmodium Liver Stage Inhibition by Halofuginone. ChemMedChem 2012, 7, 844–849. DOI: 10.1002/cmdc.201200045.
   PubMed Web of Science ®Google Scholar
• Raffa, D.; Maggio, B.; Raimondi, M. V.; Cascioferro, S.; Plescia, F.; Cancemi, G.; Daidone, G. Recent Advanced in Bioactive Systems Containing Pyrazole Fused with a Five Membered Heterocycle. Eur. J. Med. Chem. 2015, 97, 732–746. DOI: 10.1016/j.ejmech.2014.12.023.
   PubMed Web of Science ®Google Scholar
• Küçükgüzel, ŞG.; Şenkardeş, S. Recent Advances in Bioactive Pyrazoles. Eur. J. Med. Chem. 2015, 97, 786–815. DOI: 10.1016/j.ejmech.2014.11.059.
   PubMed Web of Science ®Google Scholar
• Zhang, W. M.; Xing, M.; Zhao, T. T.; Ren, Y. J.; Yang, X. H.; Yang, Y. S.; Lv, P. C.; Zhu, H. L. Synthesis, Molecular Modeling and Biological Evaluation of Cinnamic Acid Derivatives with Pyrazole Moieties as Novel Anticancer Agents. RSC Adv. 2014, 4, 37197–37207. DOI: 10.1039/C4RA05257A.
   Web of Science ®Google Scholar
• Bronson, J.; Dhar, M.; Ewing, W.; Lonberg, N. Chapter Thirty-One-to Market, to Market-2011. Annu. Rep. Med. Chem. 2012, 47, 499–569.
   Web of Science ®Google Scholar
• Shalaby, A. A.; El-Khamry, A. M. A.; Shiba, S. A.; Ahmed, A. A. A. E. A.; Hanafi, A. A. Synthesis and Antifungal Activity of Some New Quinazoline and Benzoxazinone Derivatives. Arch. Pharm. Pharm. Med. Chem. 2000, 333, 365–372. DOI: 10.1002/1521-4184(200011)333:11<365::AID-ARDP365>3.0.CO;2-2.
   PubMed Web of Science ®Google Scholar
• El-Khamry, A. A.; Shiba, S. A.; Shalaby, A. A.; Abd Alaha, A. A. Synthesis of Some New Pyrazoloquinazolinone and Quinazolinone Derivatives. J. Het. Chem. 2006, 43, 1189–1193. DOI: 10.1002/jhet.5570430509.
   Web of Science ®Google Scholar
• Abdalha, A.; Abou EL-Regal, M.; EL-Kassaby, M.; Nazeer, A. Some Reactions of 6,8-Dibromo-2-Propenyl-4H-3,1-Benzoxazin-4-One with Nitrogen Nucleophiles under Microwave Irradiation. Al-Azhar Bull. Sci. 2007, 18, 163–171. DOI: 10.21608/absb.2007.10873.
   Google Scholar
• El-Ziaty, A.; Abdalh, A.; Hamed, A.; Shiba, S.; Abdullha, A. Synthesis of Novel 2‐Propenoyl Amides, Esters, Heterocyclic Compounds and Their Screening as Antifungal and Antibacterial Agents. Eur. J. Chem. 2012, 3, 65–70. DOI: 10.5155/eurjchem.3.1.65-70.518.
   Google Scholar
• Hamed, A. A.; El-Ziaty, A. K.; Abdalha, A. A.; Shiba, S. A.; Abdullha, A. H. Synthesis and Anti-Tumor Evaluation of Some New Tranilast Analogous. World Appl. Sci. J. 2012, 19, 688–698.
   Google Scholar
• Abdalha, A. A.; Mekawey, A. A. I. Antimicrobial Susceptibility of Certain Fungal and Bacterial Strains to Dodecanamide and Quinazolinone Derivatives. World Appl. Sci. J. 2013, 24, 312–319.
   Google Scholar
• Assy, M. G.; Abdalha, A. A.; Abdel Aziz, A. E. Synthesis and Antimicrobial Evaluation of Some New Benzoxazinone and Quinazolinone Derivatives. JAC 2016, 8, 1491–1499. DOI: 10.24297/jac.v8i1.4030.
   Google Scholar
• Abou-Elmagd, W. S. I.; EL-Ziaty, A. K.; Abdalha, A. A. Ring Transformation and Antimicrobial Activity of Indolyl-Substituted 2(3H)-Furanones. Het. Commun. 2015, 21, 179–185. DOI: 10.1515/hc-2015-0008.
   Web of Science ®Google Scholar
• Hekal, M. H.; Abu El-Azm, F. S. M. Efficient MW-Assisted Synthesis of Some New Isoquinolinone Derivatives with in vitro Antitumor Activity. J. Het. Chem. 2017, 54, 3056–3064.
   Web of Science ®Google Scholar
• Mahmoud, M. R.; Abou-Elmagd, W. S. I.; Derbala, H. A.; Hekal, M. H. Synthesis and Spectral Characterisation of Some Phthalazinone Derivatives. J. Chem. Res. 2012, 36, 75–82. DOI: 10.3184/174751912X13274297624330.
   Web of Science ®Google Scholar
• Mahmoud, M. R.; Abu El-Azm, F. S. M.; Ismail, M. F.; Hekal, M. H.; Ali, Y. M. Synthesis and Antitumor Evaluation of Novel Tetrahydrobenzo [4′,5′]Thieno[3′,2′:5,6]Pyrimido[1,2-b]Isoquinoline Derivatives. Synth. Commun. 2018, 48, 428–438.
   Web of Science ®Google Scholar
• Mahmoud, M. R.; El-Shahawi, M. M.; Abou-Elmagd, W. S. I.; Hekal, M. H. Novel Synthesis of Isoquinoline Derivatives Derived from (Z)-4-(1,3-Diphenylpyrazol-4-yl)Isochromene-1,3-Dione. Synth. Commun. 2015, 45, 1632–1641. DOI: 10.1080/00397911.2015.1030760.
   Web of Science ®Google Scholar
• Hekal, M. H.; El-Naggar, A. M.; Abu El-Azm, F. S. M.; El-Sayed, W. M. Synthesis of New Oxadiazol-Phthalazinone Derivatives with Anti-Proliferative Activity; Molecular Docking, Pro-Apoptotic, and Enzyme Inhibition Profile. RSC Adv. 2020, 10, 3675–3688. DOI: 10.1039/C9RA09016A.
   PubMed Web of Science ®Google Scholar
• Mahmoud, M. R.; Abou-Elmagd, W. S. I.; Derbala, H. A.; Hekal, M. H. Novel Synthesis of Some Phthalazinone Derivatives. Chin. J. Chem. 2011, 29, 1446–1450. DOI: 10.1002/cjoc.201180264.
   Web of Science ®Google Scholar
• Abdelgawad, N.; Ismail, M. F.; Hekal, M. H.; Marzouk, M. I. Design, Synthesis, and Evaluation of Some Novel Heterocycles Bearing Pyrazole Moiety as Potential Anticancer Agents. J. Heterocyclic Chem. 2019, 56, 1771–1779. DOI: 10.1002/jhet.3544.
   Web of Science ®Google Scholar
• Ali, A. T.; Hekal, M. H. Convenient Synthesis and Anti-Proliferative Activity of Some Benzochromenes and Chromenotriazolopyrimidines Under Classical Methods and Phase Transfer Catalysis. Synth. Commun. 2019, 49, 3498–3509. DOI: 10.1080/00397911.2019.1675173.
   Web of Science ®Google Scholar
• Hekal, M. H.; Abu El-Azm, F. S. M.; Salla, H. A. Synthesis, Spectral Characterization, and in vitro Biological Evaluation of Some Novel Isoquinolinone-Based Heterocycles as Potential Antitumor Agents. J. Heterocyclic Chem. 2019, 56, 795–803. DOI: 10.1002/jhet.3448.
   Web of Science ®Google Scholar
• Abu El-Azm, F. S. M.; Ali, A. T.; Hekal, M. H. Facile Synthesis and Anticancer Activity of Novel 4-Aminothieno[2,3-d]Pyrimidines and Triazolothienopyrimidines. Org. Prep. Proced. Int. 2019, 51, 507–520. DOI: 10.1080/00304948.2019.1666635.
   Web of Science ®Google Scholar
• Hekal, M. H.; Ali, Y. M.; Abu El-Azm, F. S. M. Utilization of Cyanoacetohydrazide and 2-(1,3-Dioxoisoindolin-2-yl) Acetyl Chloride in the Synthesis of Some Novel anti-Proliferative Heterocyclic Compounds. Synth. Commun. 2020, 50, 2839–2852. DOI: 10.1080/00397911.2020.1786125.
   Web of Science ®Google Scholar
• Ramadan, S. K.; El-Ziaty, A. K.; Ali, R. S. Synthesis, Antiproliferative Activity, and Molecular Docking of Some N-Heterocycles Bearing a Pyrazole Scaffold Against Liver and Breast Tumors. J. Heterocyclic Chem. 2021, 58, 290–304. DOI: 10.1002/jhet.4168.
   Web of Science ®Google Scholar
• Prakash, O.; Khalid Hussain, K.; Aneja, D. K.; Sharma, C.; Aneja, K. R. A Facile Iodine(III)-Mediated Synthesis of 3-(3-Aryl-1-Phenyl-1H-Pyrazol-4-yl)-[1,2,4]Triazolo[4,3-a]Pyridines via Oxidation of 2-((3-Aryl-1-Phenyl-1Hpyrazol-4-yl)Methylene)-1-(Pyridin-2-yl)Hydrazines and Their Antimicrobial Evaluations. Org. Med. Chem. Lett. 2011, 1, 1–9. DOI: 10.1186/2191-2858-1-1.
   PubMedGoogle Scholar
• Bischoff, G.; Hoffmann, S. DNA-Binding of Drugs Used in Medicinal Therapies. CMC. 2002, 9, 321–348. DOI: 10.2174/0929867023371085.
   Web of Science ®Google Scholar
• Martinez, R.; Chacon-Garcia, L. The Search of DNA-Intercalators as Antitumoral Drugs: What It Worked and What Did Not Work. CMC. 2005, 12, 127–151. DOI: 10.2174/0929867053363414.
   PubMed Web of Science ®Google Scholar